Physician profile
Marien Yanes
NPI 1669979548
$1,492.59
in general payments reported to CMS, 2019-2025
16 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $300 · 2023: $473 · 2024: $175 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $924.65 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $422.97 | 2021-2025 | Liletta, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $407.71 | 2021-2025 | |
| Exact Sciences Corporation | $120.02 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Evofem Biosciences, INC. | $88.82 | 2024-2025 | Solosec, Phexx, Phexxi |
| Astellas Pharma US INC | $84.99 | 2024 | |
| Acella Pharmaceuticals, LLC | $66.07 | 2023-2025 | NP Thyroid 60 |
| Myovant Sciences INC. | $53.91 | 2022 | |
| Therapeuticsmd, INC. | $47.16 | 2021-2022 | |
| Novo Nordisk INC | $43.54 | 2023-2025 | Wegovy |
| Millicent US INC | $35.08 | 2024-2025 | Femring, Intrarosa |
| Mycovia Pharmaceuticals, INC. | $30.71 | 2023 | Vivjoa |
| Bayer Healthcare Pharmaceuticals INC. | $25.33 | 2025 | |
| Hologic Sales and Service, LLC | $20.38 | 2022 | |
| Ibsa Pharma INC. | $17.36 | 2022 | |
| Lilly USA, LLC | $14.84 | 2025 | Zepbound, Mounjaro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $13.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marien Yanes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.